Maximus, Inc. to Post Q1 2025 Earnings of $1.39 Per Share, Zacks Research Forecasts (NYSE:MMS)

Maximus, Inc. (NYSE:MMS) – Research analysts at Zacks Research cut their Q1 2025 EPS estimates for shares of Maximus in a note issued to investors on Tuesday, April 23rd. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings of $1.39 per share for the quarter, down from their prior forecast of $1.40. The consensus estimate for Maximus’ current full-year earnings is $5.42 per share. Zacks Research also issued estimates for Maximus’ Q2 2025 earnings at $1.21 EPS, FY2025 earnings at $5.36 EPS and Q1 2026 earnings at $1.22 EPS.

A number of other brokerages have also recently commented on MMS. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th. Raymond James lowered shares of Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd.

Maximus Price Performance

Shares of NYSE MMS opened at $80.63 on Thursday. The stock has a market capitalization of $4.92 billion, a PE ratio of 26.66 and a beta of 0.72. Maximus has a fifty-two week low of $72.39 and a fifty-two week high of $89.69. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. The business has a fifty day moving average price of $82.59 and a two-hundred day moving average price of $81.30.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.06. The business had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.94 earnings per share.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.49%. The ex-dividend date is Tuesday, May 14th. Maximus’s payout ratio is presently 39.74%.

Insider Buying and Selling at Maximus

In other news, CFO David Mutryn sold 8,000 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $83.95, for a total transaction of $671,600.00. Following the completion of the transaction, the chief financial officer now owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.40% of the company’s stock.

Institutional Investors Weigh In On Maximus

Hedge funds have recently made changes to their positions in the stock. SG Americas Securities LLC bought a new position in shares of Maximus in the 3rd quarter valued at $2,262,000. GHP Investment Advisors Inc. boosted its stake in shares of Maximus by 3.9% during the third quarter. GHP Investment Advisors Inc. now owns 27,193 shares of the health services provider’s stock valued at $2,090,000 after purchasing an additional 1,025 shares in the last quarter. HGK Asset Management Inc. grew its holdings in shares of Maximus by 11.8% during the third quarter. HGK Asset Management Inc. now owns 7,395 shares of the health services provider’s stock worth $552,000 after purchasing an additional 782 shares during the last quarter. Cavalier Investments LLC grew its holdings in shares of Maximus by 3.8% during the third quarter. Cavalier Investments LLC now owns 19,200 shares of the health services provider’s stock worth $1,434,000 after purchasing an additional 699 shares during the last quarter. Finally, Reinhart Partners LLC. increased its stake in shares of Maximus by 1.6% in the third quarter. Reinhart Partners LLC. now owns 209,244 shares of the health services provider’s stock valued at $15,626,000 after buying an additional 3,238 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.